Keratinocyte proliferation and keratin production in meibomian gland ductal epithelium

Keratinocyte proliferation and keratin production in the meibomian gland ductal epithelium is a physiological process that, when dysregulated, leads to ductal hyperkeratinization, a hallmark of Meibomian Gland Dysfunction (MGD) (Knop et al., 2011, Investigative Ophthalmology & Visual Science). This hyperkeratinization causes thickening of the ductal walls and obstruction of the gland orifice, preventing the secretion of meibum into the tear film and leading to evaporative dry eye (Jester et al., 1989, Investigative Ophthalmology & Visual Science). The process is influenced by various factors, including androgen deficiency, inflammatory cytokines such as IL-1, and environmental stressors (Sullivan et al., 2002, Annals of the New York Academy of Sciences). Therapeutic approaches targeting this process include the use of anti-inflammatory agents like Cyclosporine and antibiotics with immunomodulatory properties like Azithromycin, which help restore ductal patency and improve tear film stability (Liu et al., 2014, Drug Design, Development and Therapy). Because this is a complex biological process rather than a single molecular target, it is often addressed through multi-modal treatment strategies aimed at reducing inflammation and softening obstructive material (Nichols et al., 2011, Investigative Ophthalmology & Visual Science). Monitoring this process in patients typically involves clinical assessment of the lid margin and meibum quality to evaluate the efficacy of interventions.

Other names

Meibomian gland ductal hyperkeratinizationDuctal keratinization of meibomian glandsMeibomian gland keratinizationObstructive meibomian gland dysfunction mechanism

Drugs targeting this process typically act by reducing inflammatory cytokine signaling, modulating epithelial cell differentiation, or inhibiting the hyperproliferation of ductal keratinocytes to prevent gland obstruction and restore meibum flow.